Clinical Trials Directory

Trials / Completed

CompletedNCT02282592

Metabolic Syndrome and Female Breast Cancer

Metabolic Syndrome and Female Breast Cancer: a Case-control Study in Southern Brazil

Status
Completed
Phase
Study type
Observational
Enrollment
164 (actual)
Sponsor
Catholic University of Pelotas · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The role among metabolic syndrome and breast cancer risk is not well understood and must be further explored. The objective of this study is to evaluate the association between metabolic syndrome and breast cancer in Southern Brazil. In this case-control study, breast cancer patients and controls without malignant disease, matched for age (±5 years) and menopausal status, were interviewed and asked to make a glucose, HDL-cholesterol and triglycerides test. Waist circumference and blood pressure were measured using standardized procedures. Metabolic Syndrome was considered by NCEP ATP III (2001) and IDF (2006) definitions. Cases and controls were compared in relation to the presence of diagnosed MetS (yes/no), number of metabolic abnormalities identified (1 to 5) for each definition, and according to each metabolic abnormality cutoff point.

Conditions

Interventions

TypeNameDescription
OTHERObservation about the presence of metabolic syndrome

Timeline

Start date
2013-11-01
Primary completion
2014-08-01
Completion
2014-10-01
First posted
2014-11-04
Last updated
2014-11-04

Source: ClinicalTrials.gov record NCT02282592. Inclusion in this directory is not an endorsement.